Fuggle S V, Errasti P, Daar A S, Fabre J W, Ting A, Morris P J
Transplantation. 1983 Apr;35(4):385-90. doi: 10.1097/00007890-198304000-00024.
Biopsies from 46 kidneys that were subsequently transplanted were examined with monoclonal antibodies and the peroxidase-antiperoxidase technique to localize HLA-ABC and DR antigens. There was no variation in the expression of HLA-ABC which was present on all cells of the renal parenchyma. HLA-DR was found consistently on the endothelium of glomeruli and of intertubular capillaries but was only weakly expressed, or not expressed at all, on the endothelium of large vessels. The mesangium of glomeruli also stained for HLA-DR. But there was a striking variation in the expression of HLA-DR by proximal renal tubular cells in the 46 kidneys. HLA-DR was absent from tubules in 11 of 46 kidneys (23%) and probably absent or very weakly expressed in a further 8 kidneys (17%). The expression of HLA-DR in tubular epithelium was not related to the donor's age, sex, blood group, or ischemia times. However, the frequency of HLA-DR3 increased (55%) in donors of kidneys with tubular DR-negative kidneys, as compared with a frequency of 15% in donors of tubular DR-positive kidneys. Although this difference was not significant after a correction for the number of comparisons made, it suggests a genetic influence on the expression of tubular DR. The survival of tubular DR-negative kidneys was better at 1 year than that of tubular DR-positive kidneys (70% vs. 57%--not significant), and tubular DR-positive grafts may have had a higher rate of delayed function when transplanted in cases with a donor-specific positive B cell crossmatch. There was no obvious variation in the number of dendritic cells stained with antibodies to HLA-DR and the leukocyte common antigen despite prior administration of high doses of steroids to some donors before nephrectomy.
对随后进行移植的46个肾脏活检标本,采用单克隆抗体和过氧化物酶-抗过氧化物酶技术检测,以定位HLA-ABC和DR抗原。肾实质所有细胞均表达HLA-ABC,其表达无差异。HLA-DR始终存在于肾小球和肾小管周围毛细血管的内皮细胞,但在大血管内皮细胞上仅微弱表达或根本不表达。肾小球系膜也有HLA-DR染色。但在这46个肾脏中,近端肾小管细胞HLA-DR的表达存在显著差异。46个肾脏中有11个(23%)的肾小管无HLA-DR,另有8个肾脏(17%)可能无HLA-DR或表达非常微弱。肾小管上皮细胞HLA-DR的表达与供体的年龄、性别、血型或缺血时间无关。然而,与肾小管DR阳性肾脏供体中15%的频率相比,肾小管DR阴性肾脏供体中HLA-DR3的频率增加(55%)。尽管在对进行的比较数量进行校正后,这种差异不显著,但提示对肾小管DR的表达存在遗传影响。肾小管DR阴性肾脏1年时的存活率高于肾小管DR阳性肾脏(70%对57%,无显著性差异),并且在供体特异性B细胞交叉配型阳性的病例中移植时,肾小管DR阳性移植物的功能延迟发生率可能更高。尽管在肾切除术前对一些供体预先给予了高剂量的类固醇,但用抗HLA-DR抗体和白细胞共同抗原染色的树突状细胞数量没有明显差异。